Patents by Inventor Oltea SAMPETREAN

Oltea SAMPETREAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer stem cell inhibitor
    Patent number: 11400076
    Abstract: The object of the present invention is to provide a novel pharmaceutical for suppressing cancer stem cells. In the present invention, a mitochondria inhibitor comprising a 2-nitroimidazole derivative is applied to the cancer stem cell as an active ingredient.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: August 2, 2022
    Assignees: KEIO UNIVERSITY, Sun Pharma Japan Limited
    Inventors: Hideyuki Saya, Oltea Sampetrean, Naoyoshi Koike, Nobuo Kubota
  • CANCER STEM CELL INHIBITOR
    Publication number: 20200316027
    Abstract: The object of the present invention is to provide a novel pharmaceutical for suppressing cancer stem cells. In the present invention, a mitochondria inhibitor comprising a 2-nitroimidazole derivative is applied to the cancer stem cell as an active ingredient.
    Type: Application
    Filed: October 2, 2018
    Publication date: October 8, 2020
    Applicant: KEIO UNIVERSITY
    Inventors: Hideyuki SAYA, Oltea SAMPETREAN, Naoyoshi KOIKE, Nobuo KUBOTA